Skip to content

Drug interactions

Deferiprone + Obinutuzumab

Severity: Major

Deferiprone and Obinutuzumab: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Obinutuzumab frequently causes neutropenia, sometimes prolonged or late-onset. With deferiprone, the risk of severe neutropenia and infection may be compounded.

What this interaction means in plain words

Deferiprone and Obinutuzumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Deferiprone belongs to Miscellaneous; Obinutuzumab belongs to Oncology.

Evidence level: Low

Why it happens

Additive hematologic toxicity affecting neutrophils.

What to do

Avoid if possible; if both are needed, monitor absolute neutrophil count more frequently and interrupt deferiprone for neutropenia or infection.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Deferiprone and Obinutuzumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Deferiprone with Obinutuzumab?

MediHelp rates the interaction as major. Deferiprone and Obinutuzumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Obinutuzumab frequently causes neutropenia, sometimes prolonged or late-onset. With deferiprone, the risk of severe neutropenia and infection may be compounded.

How serious is the interaction between Deferiprone and Obinutuzumab?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible; if both are needed, monitor absolute neutrophil count more frequently and interrupt deferiprone for neutropenia or infection.

What other medicines interact with Deferiprone?

MediHelp also lists interactions of Deferiprone with, for example, Clozapine, Abemaciclib, Acalabrutinib. The full list is on the Deferiprone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in